Semaglutide
AMAZE 7
Novo Nordisk · Phase 3 · Recruiting · Enrollment 650
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Zenagamtide | n/r | n/r | n/r | n/r |
| Semaglutide dose 1 | n/r | n/r | n/r | n/r |
| Semaglutide dose 2 | n/r | n/r | n/r | n/r |
Not shown
- Zenagamtide: endpoint not reported
- Semaglutide dose 1: endpoint not reported
- Semaglutide dose 2: endpoint not reported